483
Steri-Pharma, LLCSteri-Pharma, LLC – FDA 483, Oct 4, 2022
Record Details
An FDA inspection of Steri-Pharma, LLC, a sterile drug manufacturer in Syracuse, NY, revealed significant deficiencies in laboratory controls and equipment calibration. The firm failed to follow and document established test procedures for growth promotion and did not adequately calibrate temperature monitoring equipment. These issues indicate a lack of control over critical manufacturing and testing processes.
View Company Profile
ID · bcefd166-90f4-4345-a237-cccc9f40a479
Other documents for Steri-Pharma, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.